MIT's new initiative combines synthetic biology and AI to develop programmable antibacterials, targeting antimicrobial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results